Drugs / Banapenem
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04200261 | Dec 2019 → Sep 2020 | — | Sihuan Pharmaceutical Holdings Group Ltd. | Unknown | No outcome recorded |
| Phase 1 | NCT03578588 | Dec 2015 → Jan 2016 | — | Sihuan Pharmaceutical Holdings Group Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Banapenem | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03578588 ↗ |
| Route | Intravenous | “administered by single or multiple intravenous infusions” PMID 30617093 ↗ Feb 2019 |